Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial

NCT07481955 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Vaginosis (BV)

Interventions

DRUG: FB 301
DRUG: Chlorhexidine 0.5%
DRUG: metronidazole 500 mg

Sponsor

Freya Biosciences ApS

Collaborators

CRS Clinical Research Services Berlin GmbH